Altrubio

Altrubio is a clinical-stage biotech treating autoimmune disorders with a lead antibody for ulcerative colitis.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series B
Initial Investment Year
2024
Altru Bio Portco Hover Image